Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.

Saved in:
Bibliographic Details
Title: Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.
Authors: Evrard YA; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Alcoser SY; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Mullendore M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Lih CJ; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Kannan VR; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Datta V; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Dutko L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Jiwani S; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Palmisano A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; General Dynamics Information Technology (GDIT), Falls Church, VA, United States., Kuhlmann L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Simpson M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Kummar S; Division of Hematology/Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States., Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Polley E; Department of Public Health Sciences, University of Chicago, Chicago, IL, United States., Li MC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Hollingshead MG; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
Source: Frontiers in oncology [Front Oncol] 2025 May 19; Vol. 15, pp. 1571635. Date of Electronic Publication: 2025 May 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1571635